Cohort Feasibility Study of an Intermittent Pneumatic Compression Device Within a Below-knee Cast for the Prevention of Venous Thromboembolism

Overview

Journal BMJ Open

Specialty General Medicine

Date 2016 Oct 7

PMID 27707834

Citations 2

Authors

Irene Braithwaite

Bernadette De Ruyter

Alex Semprini

Stefan Ebmeier

Grant Kiddle

Nigel Willis

John Carter

Mark Weatherall

Richard Beasley

Affiliations

Soon will be listed here.

Abstract

Objectives: To determine the likely enrolment rate of eligible participants into a randomised controlled trial (RCT) in which a within-cast intermittent pneumatic compression device using Jet Impulse Technology (IPC/JIT) is 1 of 3 possible interventions in a RCT for the prevention of venous thromboembolism (VTE) in the clinical setting of isolated lower limb cast immobilisation.

Design: A prospective, open-label feasibility study of the IPC/JIT device placed within a lower limb cast.

Setting: Wellington Regional Hospital Fracture Clinic.

Participants: Individuals aged 18-70 who presented with a lower limb injury requiring a minimum of 4 weeks below-knee cast immobilisation.

Intervention: Placement of an IPC/JIT device within lower limb cast.

Outcome Measures: The main outcome measure was the proportion of eligible participants who participated in the feasibility study. Secondary outcome measures included adherence to device usage throughout the study, ease of application of the device and adverse events potentially associated with its use.

Results: The proportion of potentially eligible participants for the IPC/JIT device was only 7/142 (5%), 95% CI 2 to 9.9. Devices were used for a mean (range) of 4.1 (1.9 to 10.2) hours per day and none of 7 participants had adequate adherence to the device. 3 of the 7 participants suffered an adverse event, including 1 deep vein thrombosis, 2 dorsal foot ulcer and 1 skin maceration.

Conclusions: A within-cast IPC/JIT device is unlikely to be a feasible randomisation arm for a RCT assessing possible interventions for the reduction of VTE risk in the clinical setting of lower limb injury requiring below knee cast immobilisation for a minimum of 4 weeks.

Trial Registration Number: ANZCTR 12615000192583.

Citing Articles

Transformative Deep Vein Thrombosis Prophylaxis With Sequential Compression Devices in the Care of Hospitalized Patients.

Shahbaz A, Wannakuwatte R, Mohammed C, Alzarooni A, Pendem H, Majeed F Cureus. 2024; 16(10):e70639.

PMID: 39483555 PMC: 11526840. DOI: 10.7759/cureus.70639.

Vascular impulse technology versus elevation for the reduction of swelling of lower extremity joint fractures: results of a prospective randomized controlled study.

Schnetzke M, Barbari J, Schuler S, Swartman B, Keil H, Vetter S Bone Joint J. 2021; 103-B(4):746-754.

PMID: 33789481 PMC: 9950846. DOI: 10.1302/0301-620X.103B4.BJJ-2020-1260.R1.

References

Delis K, Slimani G, Hafez H, Nicolaides A . Enhancing venous outflow in the lower limb with intermittent pneumatic compression. A comparative haemodynamic analysis on the effect of foot vs. calf vs. foot and calf compression. Eur J Vasc Endovasc Surg. 2001; 19(3):250-60. DOI: 10.1053/ejvs.1999.1048. View

BRADLEY J, Krugener G, Jager H . The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. J Arthroplasty. 1993; 8(1):57-61. DOI: 10.1016/s0883-5403(06)80108-7. View

Testroote M, Stigter W, de Visser D, Janzing H . Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization. Cochrane Database Syst Rev. 2008; (4):CD006681. DOI: 10.1002/14651858.CD006681.pub2. View

Comerota A, Chouhan V, Harada R, Sun L, Hosking J, Veermansunemi R . The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg. 1997; 226(3):306-13; discussion 313-4. PMC: 1191029. DOI: 10.1097/00000658-199709000-00010. View

Lapidus L, Ponzer S, Elvin A, Levander C, Larfars G, Rosfors S . Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized placebo-controlled, double-blind study. Acta Orthop. 2007; 78(4):528-35. DOI: 10.1080/17453670710014185. View

Lassen M, Borris L, Nakov R . Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N Engl J Med. 2002; 347(10):726-30. DOI: 10.1056/NEJMoa011327. View

Braithwaite I, Dunbar L, Eathorne A, Weatherall M, Beasley R . Venous thromboembolism rates in patients with lower limb immobilization after Achilles tendon injury are unchanged after the introduction of prophylactic aspirin: audit. J Thromb Haemost. 2015; 14(2):331-5. DOI: 10.1111/jth.13224. View

Niikura T, Lee S, Oe K, Koh A, Koga T, Dogaki Y . Incidence of venous thromboembolism in fractures around and below the knee with physical prophylaxis. Orthopedics. 2012; 35(10):e1476-82. DOI: 10.3928/01477447-20120919-15. View

Caschman J, Blagg S, Bishay M . The efficacy of the A-V Impulse system in the treatment of posttraumatic swelling following ankle fracture: a prospective randomized controlled study. J Orthop Trauma. 2004; 18(9):596-601. DOI: 10.1097/00005131-200410000-00003. View

10.

Eriksson B, Kakkar A, Turpie A, Gent M, Bandel T, Homering M . Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement. J Bone Joint Surg Br. 2009; 91(5):636-44. DOI: 10.1302/0301-620X.91B5.21691. View

11.

Collins R, Baigent C, Sandercock P, Peto R . Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration. BMJ. 1994; 309(6963):1215-7. PMC: 2541706. DOI: 10.1136/bmj.309.6963.1215. View

12.

Charles T, Mackintosh S, Fingleton J, Braithwaite I, Weatherall M, Beasley R . Efficacy of micromobile foot compression device in increasing lower limb venous blood flow. Int J Vasc Med. 2013; 2013:948769. PMC: 3844263. DOI: 10.1155/2013/948769. View

13.

. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000; 355(9212):1295-302. View

14.

Santori F, Vitullo A, Stopponi M, Santori N, Ghera S . Prophylaxis against deep-vein thrombosis in total hip replacement. Comparison of heparin and foot impulse pump. J Bone Joint Surg Br. 1994; 76(4):579-83. View

15.

Pitto R, Young S . Foot pumps without graduated compression stockings for prevention of deep-vein thrombosis in total joint replacement: efficacy, safety and patient compliance. A comparative, prospective clinical trial. Int Orthop. 2007; 32(3):331-6. PMC: 2323417. DOI: 10.1007/s00264-007-0326-9. View

16.

Morris R, Woodcock J . Evidence-based compression: prevention of stasis and deep vein thrombosis. Ann Surg. 2004; 239(2):162-71. PMC: 1356208. DOI: 10.1097/01.sla.0000109149.77194.6c. View

17.

Kock H, Schmit-Neuerburg K, Hanke J, Rudofsky G, Hirche H . Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg. Lancet. 1995; 346(8973):459-61. DOI: 10.1016/s0140-6736(95)91320-3. View

18.

Ettema H, Kollen B, Verheyen C, Buller H . Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials. J Thromb Haemost. 2008; 6(7):1093-8. DOI: 10.1111/j.1538-7836.2008.02984.x. View

19.

Jorgensen P, Warming T, Hansen K, Paltved C, Vibeke Berg H, Jensen R . Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast: a venografic controlled study. Thromb Res. 2002; 105(6):477-80. DOI: 10.1016/s0049-3848(02)00059-2. View

20.

Healy B, Beasley R, Weatherall M . Venous thromboembolism following prolonged cast immobilisation for injury to the tendo Achillis. J Bone Joint Surg Br. 2010; 92(5):646-50. DOI: 10.1302/0301-620X.92B5.23241. View